Therefore, the aim of this study was to evaluate the role of variations in PET acquisition time for image quality and SUVmax/SUVmean and thus improve the imaging protocols of 68Ga-HBED-CC-PSMA PET/MRI in patients with local and metastatic prostate cancer. The gene discussed is FOLH1; the disease is metastatic prostate carcinoma.